BioSpace News Archive

Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.

Exclusion of long-term desensitization and patient quality-of-life data by ICER fails to recognize the full value AR101 immunotherapy can deliver to the peanut allergy community

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, congratulates Cara Therapeutics (Nasdaq: CARA) on the successful initiation of its Phase 2 clinical trial of Oral KORSUVA™ (CR845/difelikefalin) for the treatment of pruritus in patients with atopic dermatitis (AD).

− Announces Planned Appointment of Jeff Poulton − Manmeet S. Soni to Resign After a Transition Period

RaySearch has received 510 clearance from the FDA in the USA for version 8B of the treatment planning system RayStation®.

BTG plc, the global healthcare company, highlighted the first publication of National Comprehensive Cancer Network pediatric acute lymphoblastic leukemia guidelines including consideration of Voraxaze®.

Hall of Famer and four time Super Bowl champion continues to feel the physical effects of his playing career that ended in 1994.

Percutaneous nephrostomy procedures have gained immense popularity over the last few years as they eliminate the need for nephrostomy tube or ureteral stent devices.

Opsens Inc. reported its results for the third quarter of 2019.

Line of CBDMEDIC™ products, which are sold to consumers via retail chains and the company’s e-commerce platform.